Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

B&B Clinical Innovations

1976 FOUNDED
M&A STATUS
101-200 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of late-stage clinical development services to pharmaceutical and biotechnology industries. The company conducts clinical trials in the fields of allergies and asthma, cardiology, gastroenterology, HIV, infectious disease dermatology, metabolic studies, oncology, osteoporosis, and urology.

Formerly Known As
Berger Boyer & Associates
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 2018 Baltimore Avenue
  • Kansas City, MO 64108
  • United States

+1 (816) 000-0000

B&B Clinical Innovations Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore B&B Clinical Innovations‘s full profile, request access.

Request full access to PitchBook

B&B Clinical Innovations Executive Team (5)

Name Title Board
Seat
Contact
Info
Sean Hart Chief Executive Officer
Arthur Berger Founder & President
Ronald Wehmeyer Chief Financial Officer
Susan Cox Chief Operating Officer
Gerald Faich MD Executive